As drug companies invest millions of dollars to find Alzheimer’s treatments, one research team is dancing to a different drummer. Actually, dancing to a drummer could be part of its investigation.
CMS dementia care pilot program to expand care delivery options
By
Kimberly Bonvissuto
Aug 01, 2023
Assisted living residents may be part of a new Medicare dementia care model that will test an alternative payment for family caregivers while expanding care delivery options to allow people living with...
Senior living operator aims to raise ‘Purple Flag’ across its memory care communities
By
Kimberly Bonvissuto
May 01, 2023
A New England-based assisted living provider is the first in the nation to seek dementia care accreditation for its entire portfolio of memory care communities through Purple Flag for Dementia Care.
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
Dementia-competent workforce, career advancement keys to improving Alzheimer’s care: Senate committee
By
Kimberly Bonvissuto
May 21, 2021
Developing a dementia-competent workforce and providing career advancement opportunities will help strengthen direct care workforce recruitment and retention, leading to a better quality of life for people...
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.
Clinton shares Alzheimer’s plans
By
Lois A. Bowers
Dec 22, 2015
Democratic presidential candidate Hillary Clinton unveiled a plan Dec. 22 to invest $2 billion per year to prevent, treat and make possible a cure for Alzheimer’s disease by the year 2025 if she...
‘Alzheimer’s crisis’ intersecting with direct care workforce challenges, association says
By
Kimberly Bonvissuto
Mar 16, 2023
The nation is facing an “Alzheimer’s crisis” as the number of older adults in whom the disease is diagnosed continues to increase amid a shortage of direct care workers, according to the Alzheimer’s...
Promising Alzheimer’s drug results hailed as ‘major milestone’
By
Kimberly Bonvissuto
Sep 29, 2022
An investigational drug showing promise in reducing cognitive decline in early Alzheimer’s disease is being hailed as having potential to “change the course” of the disease.
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.